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INTRODUCTION 
Rheumatic fever is unique among the major causes of 
cardiovascular disease in that it is the only one that is 
clearly preventable. Although the exact etiology is still 
in question, the undeniable association between rheumatic 
fever and a preceding streptococcal pharyngitis forms the 
basis for both primary and secondary prevention programs. 
To adequately treat a patient with pharyngitis proven due to 
group A beta-hemolytic streptococci is to reduce the likeli¬ 
hood of that patient's becoming a victim of RF; and by 
placing a patient with a well-documented attack of RF on 
continuous penicillin prophylaxis we can minimize the like¬ 
lihood of his having further infections with streptococci and 
therefore reduce the chance of recurrent bouts of RF. 
It is reported that, during the past 40 years, the 
epidemiology of RF has undergone significant changes in ec¬ 
onomically developed countries such as the U.S. Most ob¬ 
servers believe that acute rheumatic fever is less frequent 
than before. (Markowitz, 1972) 
Unfortunately we have reached the point where interest 
in RF in this country is diminishing more rapidly than the 
incidence of the disease. This complacency has developed 
from a false sense of security and achievement based on the 
delusion that even without additional effort, penicillin will 
lead us into the promised land of RF obsolescence. The unfor- 
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tunate byproduct of this attitude is that lack of interest 
and support on the part of many agencies endangers efforts 
to find new preventive methods and to improve and continue 
existing prophylaxis programs, (Markowitz, 1970) 
Many physicians hold the view that RF no longer remains 
a significant public health problem and report that they see 
little or no RF in their practices, A further indication of 
the decreasing emphasis on RF was observed in 1967 when the 
Michigan State Medical Society closed its three RF centers 
and discontinued its RF control program, (Parker, 1969) 
Here in Connecticut, the decline in interest in RF is 
exemplified by the loss of enthusiasm in several areas of the 
state for long-standing prophylaxis programs run by the 
Connecticut Heart Association, and can be underscored by 
quoting from an article appearing in The Hartford Courant 
on July 4, 1973, entitled "Rheumatic Fever Cases Expected to 
Set Record:" (RF is a reportable disease in Connecticut,) 
A record number of rheumatic fever cases 
in Connecticut appears likely this year. 
With half the year gone, the count so far 
equals the highest 12-month count since the 
state Health Department began keeping track of 
cases in 1965, 
An Enfield elementary school student be¬ 
came the state's 10th case last week. There 
were 10 cases in 1970 and only 3 during 1972, 
Belief in the accuracy of the number of reported cases 
in Connecticut might certainly lend strength to the argument 
that RF is, indeed, a conquered disease and that little 
effort need further be expended upon its prevention. 
However, many clinicians in Connecticut both private 
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and hospital affiliated, had personally observed more than 
3 cases of RF in 1972 in their own practices or hospital 
services. That a degree of underreporting existed was cer¬ 
tain, but no one knew what the true incidence in the state 
was. Estimates, speculation, and debate were offered in 
many forums, each based on projections from local statistics, 
and each with varying techniques of data collection and with 
different criteria for diagnosis, 
PURPOSE 
This study was then undertaken to accurately assess the 
extent and clinical picture of RF in Connecticut, It was 
felt that accurate estimates of statewide incidence would 
serve many purposes, such as indicating the magnitude of the 
problem among the different populations at risk, identifying 
the regions where the problem is greatest, and providing grounds 
for approximating how much time, money, and effort needs 
to be directed toward preventive and remedial work on the 
problem of rheumatic fever, 
EARLY PLANNING 
It was realized early in the planning phase of our study 
that no single source of data could provide an accurate pic¬ 
ture of the extent of RF in Connecticut, 
Rheumatic fever registry: Many states, Connecticut in¬ 
cluded, have established registries of RF patients who receive 
prophylactic medication. The data from such registries are 
often used as the basis for gauging the incidence of RF 
_ 
by counting the number of new cases entered annually in the 
registry.. However, underreporting is a major problem. An 
additional problem is that most registries do not provide a 
method for verifying whether the cases meet the Jones Crit¬ 
eria, As a result, registries often include a significant 
number of incorrectly diagnosed cases. In view of the inac¬ 
curacies inherent in any registry system, we decided to avoid 
using the RF registry as our basis for estimating incidence. 
Instead, we compared the names of the patients on file at the 
registry with those we had obtained as hospitalized cases of 
ARF, and could then judge the degree of underreporting to the 
registry, 
Underestimation: Sources depending upon a physician or 
medical institution to remember and report each case generally 
miss a significant proportion of the true cases in the com¬ 
munity, The degree of underascertainment depends in some 
measure on the incentive for reporting. But even the best 
methods of ascertainment will miss those cases which do not 
come to medical attention. This is particularly significant 
in a disease such as ARF in which the case fatality rate is 
low, the clinical picture is variable with many mild cases, 
and the frequency of the disease is highest among the poor 
whose medical services are often extremely limited in avail¬ 
ability and accessibility. Nothing short of a prospective 
study of a very large group of people can give more than a 
gross estimate of those cases of RF which never reach medical 
attention. Therefore, those cases were excluded from our 
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study whose medical care, if present, did not discover this 
diagnosis, and in whom treatment was therefore denied,. 
As for those patients who do reach medical attention, we 
chose for the present to deal solely with hospital admissions, 
and to leave for a later study those cases not hospitalized 
and treated as outpatients. In this way, we avoided any 
reliance on memory of cases, hoped to find reasonably accurate 
and complete records for most patients, and might then be 
able to give a quite accurate incidence figure for hospital¬ 
ized cases,. 
Population: The populations from which cases come is 
often highly selected or imprecisely defined. If, for example, 
one looks at the number of cases of RF admitted to a single 
hospital, it is frequently not clear whether the hospital 
served a defined population, and, if so, whether the cases 
arising in the population might not have been admitted to 
other hospitals. Moreover, admissions to a single hospital 
are poor indications of the frequency of the disease in the 
general population, since they reflect the local admission 
policies and the changing interests of the medical staff. 
Furthermore, defined populations such as insured indi¬ 
viduals, college students, or soldiers are highly selected 
on the basis of medical, ethnic, and socioeconomic factors, 
and therefore may not be representative of the population 
at risk for RF, For these reasons, our population was taken 
to be the entire state of Connecticut, and our incidence 
. 
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figures were derived from RF admissions to all hospitals in 
the state♦ 
Validation: Many sources accept the diagnosis of RF as 
given and have no mechanism for verifying the diagnosis. 
This can lead to a serious problem, since the diagnosis is 
on the basis of the Jones diagnostic criteria and physicians 
vary in their use of these guidelines. The fact that not all 
true cases fit the Criteria further contributes to the problem 
(Okuni, 1971) In our study, each chart was reviewed and 
information gathered with regard to many parameters. In this 
way, the diagnosis could be verified and an estimate of valid¬ 
ity given for the state, 
Comparison: This study is neither the first nor the last 
to attempt to evaluate the incidence and clinical picture of 
ARF by using retrospective hospital chart review. Wherever 
possible, our results have been compared with those of similar 
studies reported in the past 15 years. 
When reference is made to one of these studies (shown in 
figure 1), it will be by name of the author and date of pub¬ 
lication, Dates during which the study was performed, age 
and geographic restrictions, and total number of cases in 
question will not be repeated in each reference. In all cases 
undefined percentages refer to a number of cases out of the 
total in the study, (For example, when referring to Tahernia, 
1971, the percentage 35% refers to 35% of the total 100 admis¬ 
sions, or 35 admissions, unless otherwise stated.) 
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Figure 1: A Selected List of Retrospective Studies of Rheumatic 
Fever Against Which the Data from the Present Study 
can be Compared. 
AUTHOR 
YEARS OF 
STUDY ADMISSIONS AGES 
REGION OR HOSPITAL 
UNDER STUDY 
Goldring 
1968 
1956-1965 195 5-15 St. Louis Children’s 
Hospital 
Feinstein 
1 962a 
1958-1960 275 5-1 5 
* 
Irvington House 
M c C u e 
1970 
1965-1968 142 pediatric 
ward 
Medical College of 
Virginia Hospital 
Brownell 
1 973 
1963-1965 298 5-1 4 Lower East Side of 
Manhattan, N.Y.C, 
G ordis 
1969 
1960-1964 270 5-19 Baltimore, Maryland 
Hall 
1961 
1930-1954 1 434 all Malmo, Sweden 
Saslaw 
1962 
1955-1958 83 all greater Miami, Florida 
Mayer 
1 963 
1935-1958 792 pediatric 
ward 
Bellevue Hospital, 
N.Y.C. 
5 i t a j 
1970 
1 969 277 all region in 
Czechoslovakia 
Saksena 
1969 
1969 60 all region in 
India 
Tahernia 
1971 
1958-1969 1 00 all region in southern 
Iran 
Irvington House is a regional referral hospital for the 
acute care and convalescence of children with rheumatic fever. 
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MATERIALS AND METHODS 
From the Journal of the American Hospital Association, 
August 1, 1971 (45 (II):46-48), a list of all 67 hospitals 
in the state of Connecticut was obtained. By eliminating 
from this list all convalescence homes, Federal penal or 
military institutions, and psychiatric hospitals, we con¬ 
structed a list of the 38 acute medical care hospitals in 
the state which were likely to represent the great majority 
of RF admissions (see figure 2), 
A letter was drafted and sent to both the chief admin¬ 
istrator and the chief medical librarian at each hospital 
(see Appendix) to acquaint them with our study, assure them 
of the confidentiality of any data we might obtain, stress 
the importance of the undertaking and the backing of the 
Connecticut Heart Assocation, and request their assistance 
and permission in reviewing all the charts in their hospital 
1967-1972 with the diagnosis of acute rheumatic fever on 
discharge. 
Approximately one week after the mailing of the letters 
to the hospitals (the letters were sent out in groups of 10- 
15), the author personally called the chief medical librarian 
at each institution to confirm receipt of the letter, answer 
any questions, and, when possible, confirm a date upon which 
the charts might be reviewed. It was asked that all charts 
with ARF as either primary or ancillary discharge diagnosis 
be pulled for inspection. For the majority of the hospitals 
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using the HICD (Hospital International Classification of 
Diseases), this corresponded to categories 390 (ARF without 
carditis), 391 (ARF with carditis), and 392 (Sydenham’s 
chorea). The categories before modification of the HICD in 
1969 were 400, 401, and 402 respectively. 
As necessary, further phone calls were made to each 
hospital until a firm appointment for chart review could be 
made. 
The author then personally travelled to each of the 38 
hospitals in the study and reviewed the charts of all ad¬ 
missions for ARF from 1967-1972, using the coding form described 
below (see Appendix), All available data were recorded as 
found in the chart, except in the case of obvious inconsist¬ 
encies (e,g. If the discharge summary stated that the highest 
A50 during the hospitalization was 500, yet there were two 
laboratory slips for that patient and during that hospitali¬ 
zation which gave values of 625, the value of 625 would have 
been recorded as the highest A50 during the hospitalization,) 
Only hospitalizations for the acute phase of an attack 
were included in our study. Charts were excluded for three 
main reasons. Admissions for convalescence directly following 
discharge or a few days thereafter were excluded by comparing 
names and birth dates of all admissions. Also, in several 
charts, the discharge diagnosis did not match the coding by 
HICD, The majority of these 'were patients admitted with 
pericarditis, rheumatic heart disease, or a totally unrelated 
. 1.' 
’ 
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cause, who were erroneously cataloged as 390 or 391. Finally, 
some admissions gave firm discharge diagnoses followed by a 
list of "rule-outs" which had been satisfactorily ruled out 
(e.g, discharge diagnosis-gouty arthritis, R/0 rheumatoid 
arthritis, R/0 ARF, R/0 systemic lupus erythematosis), In 
this case, when it was clearly not intended to imply that ARF 
was one of the discharge diagnoses, the chart was excluded. 
In 1955, the Connecticut Heart Association established a 
registry to facilitate the distribution of low-cost penicillin 
to RF patients for continuous prophylaxis against recurrent 
attacks. Currently, under agreement between the Connecticut 
Heart Association and the Connecticut Pharmaceutical Associa¬ 
tion, pharmacists in the state sell penicillin at low cost to 
persons who are registered by their physicians as having had 
RF, There are no age or income limits on eligibility, (SpineHi, 
1961 ) 
Following the completion of chart reviews at all 38 
hospitals, the author reviewed the files of the Connecticut 
Rheumatic Fever Registry, for the years 1967-1972 in an 
effort to find how many patients known to have been admitted 
to hospitals in the state during that period, managed to be 
registered with the Heart Association, and how many were 
still on the active registry. 
After all data was collected, it was found that there 
were several gaps, with a few hospitals unable to provide 
data on the earliest years under study. It was decided to 

cut the time under study to the five-year period 1966-1972 
to avoid the majority of the discontinuities in our information. 
It must, however, be noted that in addition to the unknown and 
hopefully small number of charts which should be included in 
the study but, by omission, were not pulled from the hosoital 
records, two institutions were unable to provide any information 
for the year 1968: McCook Hospital and Norwalk Hospital* The 
former’s charts are apparently in storage with the State of 
Connecticut and unavailable, and the latter never centrally 
classified their admissions with regard to discharge diagnosis 
prior to 1969. These two lapses hopefully only account for a 
handful of charts and introduce no more than a 1-2% error in 
any of our data* 
Upon completion of data collection, all information was 
punched onto 80-column IBM cards, a program for analysis of 
the data was written in the language DATATEXT, and the pro¬ 
gram was run at the Yale University Computing Center, 
THE CODING FORM 
In order to facilitate computerized analysis of our data, 
a coding form (see Appendix) was devised which would lend it¬ 
self to easy transferral of data to 80-c.olumn IBM punch cards. 
In general, the code 1 was defined as an unqualified positive 
response, 2 as an unqualified negative response, 8 as the 
presence of equivocal or questionable information, and 9 as 
the lack of sufficient information to further categorize. 
The heading of the coding sheet included spaces for the 
31SI' 
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hospital name, date of the data collection, name, address, 
and birthdate of the patient, and dates of admission and dis¬ 
charge. 
The body of the coding form began with study number, a 
5-digit number uniquely identifying each patient. The first 
two digits represented a hospital code 01 to 38 and the fourth 
and fifth digits represented a patient code 01 to 99 assigned 
in order as charts were reviewed at each hospital. The third 
or middle digit was used for recording instances of multiple 
admissions of the same patient for ARF during the period of 
study. For a patient’s first admission, the digit was 0, for 
his second admission, or first readmission, the digit became 
1, and so forth. When the data was transferred to punched 
cards, these 5 digits, as well as all further information on 
the coding form, were simply transferred to the first five 
columns of the card, (e,g, 01025 indicates the identifying num¬ 
ber of the 25th patient reviewed at hospital 01, which was his 
first admission for ARF for the period under study,) 
Column 6 was used for the question Was the chart available? 
the answer to which was universally yes. The coding was 1 
for yes and 2 for no. 
Column 7 identified the patient with respect to race and 
sex; 1-white male, 2-white female, 3-black male, 4-black female. 
Columns 8 and 9 were used for the patient’s age on admis¬ 
sion rounded off to the nearest year. 
Columns 10 and 11 were used for the month of admission, 
01-January to 12-December. 
. ' n 
Column 12 was used for the last digit of the year of 
admission; 7-1967, 8-1968, 9-1969, 0-1970, 1-1971, 2-1972, 
Colums 13-15 were used for the number of days of hospit¬ 
alization , In the cases in which a patient was discharged 
to a convalescent home, the length of hospitalization was 
taken to be the total length of the acute hospitalization, 
ending with transferral to the convalescent home. In the 
event of a recrudescence, defined in our study as rebound or 
reappearance of symptoms after total suppression by treatment 
and within 2 months of discharge, the total length of hospit¬ 
alization was the sum of the initial and the recrudescent 
admissions, and the two were combined with regard to clinical 
manifestations, (e,g, A diagnosis of carditis during either 
the initial or readmission was sufficient to classify the 
patient as having carditis,) 
Columns 16-22 were used for the patient's chart number. 
Column 23 was used for disposition; 1-discharge home, 
2-convalescent home or hospital, 3-died, 4-other, 9-no in¬ 
formation. 
Column 24 was used for carditis; 1-yes, or present, 2-no 
or absent, 8-questionable, 9-no information. In cases in 
which the diagnosis of carditis was made in the chart a "yes" 
was coded unless the diagnosis was admitted in the chart to 
rest solely on the basis of a prolonged P-R interval on ECG, 
in which case, in the absence of other findings, murmur, rub, 

or x-ray changes, the patient was coded as "no," In instances 
in which no mention of carditis was found, a minimal criterion 
for "yes" was a 2/6 systolic murmur heard at the apex and rad¬ 
iating to the axilla,. When a "murmur" or "systolic murmur" 
was mentioned as an important finding with no further infor¬ 
mation, the patient was placed in the "yes" category. Quest¬ 
ionable categorization was used mainly for charts in which 
the question of carditis was openly raised during hospitali¬ 
zation, often with several consultations and differing opinions 
Column25 was used for migratory polyarthritis; 1-yes, 
unable to qualify further, 2-no, 3-one joint by history alone 
with no signs on examination, 4-more than one joint by history 
alone, 5-one joint with evidence on examination, 6-more than 
one joint with evidence on examination, 6-questionable, 9-no 
information. Information in this category was usually suf¬ 
ficient to place the patient in one of the well defined categor 
ies 3 through 6, 
Columns 26, 27, and 28 were used for the remaining three 
major Jones criteria, respectively, chorea, erythema marginatum 
and subcutaneous nodules. Each was scored exactly the same 
as column 24 and exactly as columns 29-34 with 1-yes, or pres¬ 
ent, 2-no, or absent, 8-questionable, 9-no information. The 
information in these areas was sparse on many charts, 
"Normal neurological" was allowed as sufficient evidence 
against chorea, and "skin-normal" as satisfactory evidence 
■ 
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against erythema marginatum and subcutaneous nodules.. Al¬ 
though these are less frequent manifestations than either 
carditis or arthritis, it is difficult to measure the degree 
of underdiagnosis, In cases in which the history sounded 
suspicious but not certain (i.e, "a rash 4 days prior to 
admission") the patient was placed in the questionable cat¬ 
egory. 
Column 29 was used for fever, as evidenced by any single 
o o 
reading greater than or equal to 100,4 F, (38 C,), This in¬ 
formation was obtained most commonly from the temperature 
charts when they were available. 
Column 30 was used for arthralgia, and was coded as 
present even in the presence of polyarthritis, as attempts 
were being made to depict the true clinical picture of the 
average RF patient in Connecticut, Arthralgia is eliminated 
as a minor criterion when polyarthritis is used as a major 
criterion, and this was considered in our evaluation of the 
Jones criteria. 
Column 31 was used for prior rheumatic heart disease, 
coded as "yes" only in the event of a statement to the affirm 
ative, with or without substantiating murmur. The descrip¬ 
tions of murmurs were far too imprecise to allow a retrospec¬ 
tive decision on RHD. 
Column 32 was used for prolonged P-R interval on ECG, 
and was coded as positive or negative if so mentioned by the 
. 
-16- 
physician reading the ECG, or as positive if greater than 0,22 
seconds. The region 0,20 to 0,22 seconds was scored as ques¬ 
tionable without further mention in the chart. 
Column 33 was used for elevated white blood count, 
greater than or equal to 12,000 per cubic millimeter on at 
least one occasion. 
Column 34 was used for recent scarlet fever, 
and was scored as present only when such mention was found 
in the chart and within 2 months prior to admission. 
Column 35 was used for acute phase reactants, or eryth¬ 
rocyte sedimentation rate, and C-reactive protein. The coding 
was 1-both E5R and CRP done, E5R elevated, CRP normal; 2-both 
E5R and CRP done, E5R normal, CRP positive; 3-both E5R and 
CRP done, both positive; 4-both E5R and CRP done, neither pos¬ 
itive; 5-ESR only done, and elevated; 6-CRP only done, and 
positive; 7-E5R only done, and normal; 8-questionable or con¬ 
tradictory results; 9-no information. The CRP was regarded 
as positive if any reading other than "negative" was obtained 
("trace" "Imm" or any other reading was regarded a positive), 
E5R was regarded as positive depending on the hospital's 
level of normal. In general, ESR's over 20 mm/hour (Wintrobe) 
were considered elevate. 
Column 36 was used for previous rheumatic fever; 2-no 
3-yes, by history alone, 4-yes, by history and hospitalization, 
8-questionable, 9-no information. "History alone" was coded 
- 
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in cases in which the patient claimed to have had RF diag¬ 
nosed by a physician, but was at most bedridden for a period, 
"Yes, by history and hospitalization” was coded when either 
the patient had a documaneted hospitalization for RF, or 
claimed to have been hospitalized for RF, and is thus a more 
certain category for previous RF, 
Column 37 was used for throat, culture on admission and 
was coded for the first throat cultures taken after admission 
(within 72 hours after admission and before inpatient anti¬ 
biotics were begun); 1-positive for group A beta-hemolytic 
streptococci; 2-negative for group A beta-hemolytic strep¬ 
tococci; 3-not done; 7-negative for streptococci, but after 
the patient had been taking antibiotics prior to admission. 
Column 38 was used for the highest A5D in the hospital, 
and corresponds to the highest A50 during the admission,; 
0-less than or equal to 50 Todd Units; 1-100 Todd Units; 2- 
125; 3-166; 4-250; 5—333; 6-500; 7-625; 8-greater than or 
equal to 833 Todd Units; 9-no information; X-not done. The 
A50 levels were coded as the closest level when they fell 
between coding points (150 was coded as 166), "No informa¬ 
tion" indicated that the test was ordered or mentioned, but 
that no results can be found in the chart, "Not done" indi¬ 
cates that there is no mention of the test and no order for it. 
Columns 39-42 were used to deal with the question of 
preceding streptococcal pharyngitis. 
. 
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Column 39 dealt with the question, "Did the oatient 
have a preceding upper respiratory infection?1* 2-no; 3-yes, 
but no further information was available; 4-yes, and he was 
seen by a physician; 5-yes, but he was not seen by a physician 
8-questionable; 9-no information. The answer to this and 
the following 3 questions was based on a combination of 
information from the chart (progress notes, discharge sum¬ 
mary, and nurses'notes), 
Column 40 was used for the physician’s diagnosis of 
the preceding respiratory infection, and was only applic¬ 
able for those patients who admitted in column 39 to having 
had such an infection; 1-a throat culture was taken and was 
positive for group A beta-hemolytic streptococci; 2-a throat 
culture was taken but was negative for group A beta-hemolytic 
streptococci; 3~no culture was taken, but the clinical appear¬ 
ance was that of streptococci; 4-no culture was taken, and 
the clinical appearance was not that of stretptococci; 7-not 
applicable, a category including all patients who denied a 
prior respiratory infection and those who had a prior infec¬ 
tion but were not seen by a physician; 8-questionable; 9-in¬ 
sufficient information. 
Column 41 was used for the physician’s treatment of the 
preceding streptococcal pharyngitis; 0~no treatment was given; 
1-treatment was given, but we do not know any further de¬ 
tails; 2-treated with antibiotics, but for less than ten 
days (stopped either by the patient or on the basis of medical 

advice); 3-antibiotics were prescribed for 10 days, but were 
not taken; 4-antibiotics were prescribed for 10 days but we do 
not know whether they were taken; 5-antibiotics were pre¬ 
scribed for 10 days and were taken; 6-antibiotics were given 
intramuscularly; 7-not applicable, including all patients 
denying preceding respiratory infection and those not seen 
by a doctor; 8-questionable; 9-no information. 
Column 42 was used to show where the patient was seen 
for his respiratory infection; 1-personal or private physi¬ 
cian; 2-outpatient department or emergency room of the hospi¬ 
tal to which the patient was ultimately admitted for ARF; 
3-outpatient department or emergency room of a hospital other 
than the one to which the patient was ultimately admitted for 
ARF; 4-other, usually treatment as a patient in a hospital 
for an unrelated complaint; 7-not applicable: 8-questionable; 
9-no information. 
Column 43 dealt with the question, "Did the admission 
satisfy the modified Jones Criteria?" with 2-no; 3-yes, 
with 2 major criteria; 4-yes, with 1 major and 2 minor cri¬ 
teria; 5-yes with Sydenham's chorea but less than 2 minor 
criteria; 8-questionable; 9-no information. For this 
question, the acceptable major manifestations were carditis, 
polyarthritis, chorea, erythema marginatum, and subcutan¬ 
eous nodules. The acceptable minor criteria were fever, 
arthralgia (if not using polyarthritis as a major criterion), 
previous RF or rheumatic heart disease, positive acute phase 
ano arii ned* 
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reaction (elevated ESR or positive CRP or elevated WBC), and 
prolonged P-R interval on ECG, It was not required that a 
patient have supporting evidence of a preceding streptococcal 
infection for fulfilling thie Jones Criteria, as this was 
handled separately. 
Column 44 was used for attack number; 1-first attack of 
RF; 2-second attack of RF; 3-third or greater attack; 4-recur¬ 
rence unable to be more accurately categorized; 8-questionable; 
9-insufficient information for an answer, 
Column 45 dealt with the question, "If this admission is 
a recurrence, was the patient on prophylaxis at the time of 
his admission?" with 1-yes, the patient had prophylactic med¬ 
ication prescribed and claimed to be taking it regularly; 2- 
yes, the patient had prophylactic medication prescribed, but 
admitted to occasional omissions; 3-yes the patient had pro¬ 
phylactic medication prescribed, but we do not know whether 
or not he was taking it regularly; 4-no, the patient did not 
have prophylactic medication prescribed; 7-not applicable; 
8-questionable; 9-insufficient information. 
Column 46 was used to indicate whether the patient 
had rheumatic heart disease on discharge; 1-yes; 2-no; 
7-not applicable, due to the death of the patient; 8-con- 
tradictory evidence precludes a reasonable decision; 9- 
insufficient evidence. Again, in this question, the word of 
the chart was taken above all, unless the evidence upon 
/ : £ i; ... ■... ; i s 
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which the diagnosis was based was stated and was clearly in¬ 
correct (e.g, "RHD on discharge diagnosed by a 2/6 systolic 
murmur heard at the apex,"). 
Column 47 was used for the discharge diagnosis by HICD; 
1-390, ARF without carditis (400 before 1969); 2-391, ARF with 
carditis (401 before 1969); 3-392, Sydenham's Chorea (402 
before 1969), 4-393-398 (410-416) chronic RHD; 6-other; 7-not 
coded by HICD, for those hospitals using other systems; 8- 
questionable; 9-no information. 
Column 48 was used for discharge diagnosis, 1-acute 
rheumatic fever, 2-question of rheumatic fever, 3-history 
of rheumatic fever, 4-question of history of rheumatic fever, 
5-not rheumatic fever, 6-other, 8-questionable, 9-no informa¬ 
tion. 
Column 49 was used to indicate whether the patient was 
ever reported to the Connecticut Heart Association Rheumatic 
Fever Registry when applying for the penicillin prophylaxis 
program, 1-yes, 2-no, 7-not applicable, due to the death of 
the patient, 8-questionable, 9-no information. These data 
were obtained by cross-checking the name of each patient 
registered with the list of names of patients hospitalized, 
and may contain inaccuracies due to the incorrect transcrip¬ 
tion of names or changes in names after admission to the hos¬ 
pital and prior to registration. 
Column 50 was used to indicate the number of days from 
3 T53f1 “IL M-:: JIT, 
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admission to the hospital for ARP until registration with the 
RF registry; 1-less than one month; 2 - o n e to six months; 3-six 
months to one year; 4-more than one year; 7-not applicable; 
8- questionable; 9-no information. 
Column 51 was used to indicate whether the patient was 
currently on the active registry with the Connecticut Heart 
Association, 1-yes, 2-no, 7-not applicable, 8-questionable, 
9- no information. 
vrion nnt; i^rli 
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RESULTS AND COMPARISONS 
INCIDENCE 
The extent of an illness such as acute rheumatic fever 
is better measured in terms of morbidity than mortality, 
because the case fatality rate, the number of people dying 
from RE among those who have the disease, is very low. The 
most frequently used morbidity indices are incidence (the 
number of new cases in a population during a specified time 
period) and prevalence (the number of persons with the disease 
in a specified population at a point in time.) (Markowitz, 
1 972) 
Has there been any change in the incidence of ARF over 
the past decades? Unfortunately, good comparative data from 
different periods of time in the same population are very 
difficult to obtain. In different periods, varying methods 
of ascertainment and validation of cases are used by inves¬ 
tigators. In addition, as a result of population shifts, 
studies of the same geographical area at separate time periods 
frequently compare dissimilar populations. 
In spite of these drawbacks, a decline in the incidence 
of ARF during the recent past has been shown by several 
authors. However, reliable figures on the size of the decline 
are difficult to find and the uncertainties of such estimates 
are obvious. 
In 1962, 5tamler in Chicago estimated the incidence of 
i . ^dmurr 
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RF as 35-45 new cases per 100,000 children ages 5-15 per 
year, using combined data from six surveys. Twenty years 
earlier, Collins estimated the Chicago attack rate as 100 
to 120 per 100,000 children, (McCue, 1970) 
Circumstances in Malmo, Sweden, a city with a single 
hospital serving a well-defined population completely cov¬ 
ered by health insurance, render this town uniquely suit¬ 
able for incidence estimates. Incidence figures of hospital¬ 
ized patients in Malmo declined from 34 cases per 100,000 
children in the period 1930-1934 to 21 cases per 100,000 
children in the period 1950-1954, (Hall, 1961) 
However, the decline in reported frequency of RF as 
well as mortality from this disease (Quinn, 1970) does not 
necessarily imply a massive reduction in its prevalence. 
Much of the change could be attributed to diminishing sever¬ 
ity of the disease. Necropsy analyses have reported an 
incidence of rheumatic valvular disease varying between 1 and 
6%, A study between the years 1941 and 1955 reported this as 
the actual cause of death in less than 50%, This 15 year 
study showed no reduction in the overall incidence at nec¬ 
ropsy, though the clinical severity showed a decline from 
1941 to 1955, This suggests that subclinical and atypical 
forms of the disease may exist in larger numbers than pre¬ 
viously realized, (Besterman, 1970) 
In our study of hospitalized cases of ARF in the state 
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Figure 2: Hospital Admissions for Acute Rheumatic Fever in 
Connecticut by Years, 1968-1972 
of Connecticut for the period 1968-1972 we obtained data on 
446 attacks, an average of 89 attacks per year. These ad¬ 
missions are broken down by years according to figure 2, 
There seems to be a declining trend even during the five 
years under study, with 111 cases in 1968 and only 69 cases 
in 1972, This decrease becomes even more significant when 
we remember that the majority of the gaps in our data, and 
hence the greatest degree ofunderestimation, occurred in the 
first year of our study. We would thus expect an even higher 
number of cases in 1968 were we able to obtain information 
on all of them. 
The overall incidence figure for Connecticut over the 
entire 5-year period 1968-1972 (taking the total population 
■ 
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as 3,000,000, the actual value in 1 970, the midpoint of 
our study) is 3,0 admissions for ARF per 100,000 total 
population per year. When broken down on an annual basis, 
using accurate population estimates for each year, we ob¬ 
tain a decrease from an incidence of 3.6 per 100,000 in 
1968 to 2,2 per 100,000 in 1972, In any event, it is clear 
that there were many more cases of rheumatic fever than the 
10 reported during 1970 and the 3 during 1972, 
Vi hen comparing these data with other studies, we find 
that our incidence figures are considerably lower than al¬ 
most any other with the exception of the study done in great¬ 
er Miami, Florida, 1955-1958, which also reported an incid¬ 
ence of 3 hospitalizations per 100,000 total population, 
(Saslaw, 1962) The Baltimore City Study, using techniques 
quite similar to our own, found 15,6 admissions per year for 
the period 1960-1964 per 100,000 population ages 5-19 (Gordis, 
1969a), Quinn studied the incidence in Nashville, Tennessee 
from 1963 to 1965 and reported an incidence of 12,6 per 
100,000 total population (Quinn, 1967), and the incidence in 
the Lower East Side of Manhattan, N.Y.C. was reported, in 
a study from 1963-1965 to be 61 per 100,000 population ages 
5-14, (Brownell, 1973) 
Vie can explain some of the difference by the fact that all 
of the studies with the exception of that performed in Miami 
and our own dealt with a highly populated metropolitan area. 
. ;, -V 
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Crowding and demographic factors present in cities are known 
to increase the incidence of RF in a population, so perhaps 
we might review our data with an eye to an urban-rural dif¬ 
ferentiation. (Gordis, 1969b), (Stollerman, 1961) 
If we break down the state of Connecticut into cities 
with populations over 85,000 and communities under 85,000, 
we find that 272 of the total 446 admissions occurred in 
cities of greater than 85,000 (New Haven, Bridgeport, 
Stamford, Hartford, Waterbury, New Britain), but that these 
cities make up only about one fourth of the state’s population. 
This gives us a city incidence figure (averaged over the 5 
years of 7,1 per year per 100,000 urban population and a non- 
city incidence figure of 1,5 admissions per year per 100,000 
non-urban population. 
In judging whether the incidence of ARF in Connecticut 
has changed over the past several decades, we can compare 
the present study with one done from 1934-1938 by the Con¬ 
necticut State Department of Health (Paul and Deutch, 1941) 
and find that the incidence at that time was calculated to be 
62 hospitalizations per year per 100,000 total population. 
Unfortunately, these admissions were not screened, but were 
obtained by questionnaire from the hospitals. It is also 
of interest to compare the number of admissions to each hos¬ 
pital 1968-1972 (figure 3) with those of 1934-1938, We find 
that in the earlier 5-year span, there were 1001 total ad- 
. 6i. ■ ■; r.--.:« j-r.c r 
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Figure 3: Total Admissions for Acute Rheumatic Fever 
by Hospital, 1968-1972 
(446) 
ADMISSIONS % OF TOTAL 
1, Bridgeport Hospital, Bridgeport 34 7,6 
2. Park City Hospital, Bridgeport 11 2.5 
3* St. Vincent's Hospital, Bridgeport 11 2.5 
4, Bristol Hospital, Bristol 6 1.4 
5. Danbury Hospital, Danbury 20 4.5 
6. Griffin Hospital, Derby 11 2.5 
7. Greenwich Hospital, Greenwich 12 2.7 
8. Hartford Hospital, Hartford 35 7,9 
9. Mount Sinai Hospital, Hartford 9 2.0 
10, St, Francis Hospital, Hartford 
11, University of Connecticut Hospital, 
25 5.6 
McCook Division, Hartford 8 1.8 
12, Manchester Memorial Hospital, Manchester 6 1,4 
13, Meriden-Wallingford Hospital, Meriden 
14, World War II Veterans' Memorial 
9 2.0 
Hospital, Meriden 3 0.7 
15, Middlesex Memorial Hospital, Middletown 22 5,0 
16. Milford Hospital, Milford 
17, New Britiain General Hospital, 
2 0.5 
New Britain 28 6,3 
18, Hospital of St, Raphael, New Haven 8 1,8 
19, Yale-New Haven Hospital, New Haven 
20. Lawrence and Memorial Hospitals, 
25 5,6 
New London 9 2,0 
21, New Milford Hospital, New Milford 4 0,9 
22, Newington Children's Hospital, Newington 2 0,5 
23. Norwalk Hospital, Norwalk 10 2.2 
24. William W, Backus Hospital, Norwich 7 1,6 
25. Day Kimball Hospital, Putnam 23 5,2 
26. Rockville General Hospital, Rockville 1 0.2 
27. Sharon Hospital, Sharon 4 0,9 
28. Bradley Memorial Hospital, Southington 
29, Cyril and Julia Johnson Memorial 
1 0,2 
Hospital, Stafford Springs 1 0,2 
30, St. Joseph's Hospital, Stamford 10 2.2 
31, Stamford Hospital, Stamford 
32. Charlotte Hungerford Hospital, 
13 2.9 
Torrington 4 0.9 
33. St, Mary's Hospital, Waterbury 31 7,0 
34, Waterbury Hospital, Waterbury 
35. Windham Community Memorial Hospital, 
24 5,4 
Willimantic 10 2.2 
36. Winsted Memorial Hospital, Winsted 
37, Veterans Administration Hospital, 
3 0.7 
West Haven 
38, Veterans Administration Hospital, 
1 0.2 
Newington 3 0.7 
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missions as compared with 446 in the present study. Granted 
the methodologies were different, the population has changed 
in Connecticut (1,6 million in 1935, 3,1 million in 1972), and 
the diagnostic criteria for RF have been altered several times; 
nevertheless, the feeling remains that the incidence of ARF 
in the state has been declining and continues to decline, 
A final correction factor that we may want to add to 
our incidence figures would be an estimate of the per cent 
of non-hospitalized cases. This is an area in which we have 
undertaken no direct investigation; however, several studies 
in the literature estimate that about 60% of all cases of ARF 
are hospitalized. 
In Pennsylvania, a questionnaire was sent to every 
physician in the state and then a personal interview was con¬ 
ducted with a random sample of non-responders. This yielded 
the information that 50-75% of all cases of RF reported were 
hospitalized, (Spector, 1968) In Baltimore, 700 practicing 
physicians were surveyed to estimate the proportion of RF 
patients who wer treated as outpatients, and it was found that 
64% were hospitalized, (Gordis, 1969a) In greater Miami, it 
was found that, of 83 patients studied, 51, or 61% were hos¬ 
pitalized, (Saslaw, 1962) Thus, if we use 60% as a correction 
factor, for our presumed non-hospitalized cases in Connect¬ 
icut, we calculate an average of 150 total cases per year, 
or an incidence of 5,0 per year per 100,000 population. 
■ ■ ■ : ■ . 
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Figure 4: Total Admissions by Race and Sex 
(figures in parentheses represent I of total admissions) 
White 
Black 
Total 
Sex 
Male Female Total Race 
187 (42) 170 (38) 357 (80) 
39 (9) 50 (11) 89 (20) 
226 (51) 220 (49) 446 (100) 
READMI55I0N5 
The 446 admissions studied represented 431 patients, 11 
of whom were admitted twice during the period of study, and 2 
who were admitted on three separate occasions during the study, 
SEX - see figure 4 
We. found a roughly equal number of males and females ad¬ 
mitted in the study, 226/446 (51%) males and 220/446 (49%) fe¬ 
males, Although it has been stated that RF is more common 
among girls, available data do not show such sex differences. 
Males and females have been found to be nearly equal in studies 
done in Manhattan by Brownell, 1973 (51% males, 49% females), 
in Bellevue by Mayer, 1963 (50% males, 50% females), in St, 
Louis by Gcldring, 1 968 ( 51% males, 49% females), in Missouri 
by Allen, 1965 (50% males, 50% females), and by Hall in Malmo, 
Sweden, 1961, 
RACE - see figure 4 
We found a 4 to 1 ratio of Whites to Blacks in our 
study group with 357/446 (80%) of the admissions Whites and 
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89/446 (20$) of the admissions Blacks. It has long been 
suggested that RF occurs more commonly in certain ethnic 
groups. Earlier in this century, the Irish were considered 
particularly prone to the disease and Blacks less susceptible 
(Markowitz, 1972) However, no studies of racial liability 
have ever been properly controlled with respect to cultural 
and religious practices, housing, and the other environmental 
variables which are closely correlated with racial genotype 
and many of which are also correlated with incidence of RF, 
It is impossible to say what part, if any, ethnic origin 
per se plays in the epidemiology of the disease, (Acheson, 
1 965 ) 
Reports of Black to White ratios from 2 to 1 (Quinn, 
1967) to 2,5 to 1 (Gordis, 1969a) to 6 to 5 (McCue, 1970) 
abound in the literature; few are corrected for population 
distribution in the area under study and none have been able 
to provide any explanation or hypothesis on the basis of race 
AGE - see figures 5a and 5b 
Although ARF is accepted as a disease of childhood and 
adolescence, it is not sufficiently appreciated that attacks 
may occur in adults right up to the fourth, fifth, and even 
sixth decade, (Wee, 1966) For this reason, it was decided 
not to confine our study to children 5-15 or 5-19 as is often 
done. 
ARF is uncommon in children under 5 years of age and 
very rare under 2, (Rosenthal, 1968), (Waly, 1971) In our 
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Figure 5a: Incidence of Rheumatic Fever Hospitalizations by Age 
Figure 5b: Incidence of Rheumatic Fever Hospitalizations by Age Group 
AGE IN YEARS 
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study, we found only one admission under 2 years of age and 
11/446 (2.5%) under the age of 5, Medley (1940) reported that 
0,7% of 2324 patients had their initial attack under 2 years 
of age and 8,4% under the age of 5, 
The incidence of initial attacks of RF decreases after 
puberty, probably because exposure to streptococci decreases 
during adult life. However, RF is still seen in young adults 
and it has been shown that susceptibility to RF remains 
relatively high until at least 22 year of age, (Markowitz, 
I 972) 
We found 27% of our admissions ages 0-9 (119/446) as 
compared with 25% (Sievers, 1971), 23% (Saslaw, 1962), and 
11% (Hall, 1961). 
Forty-eight per cent of our admissions (208/446) were 
among the 10-19 group as compared with 23% (Sievers, 1971), 
23% (Hall, 1961), and 49% (Saslaw, 1962). 
In the group over 20 years of age we found 25% (119/446) 
of our admissions as compared with 28% (Saslaw, 1962), 22% 
(Allen, 1965), 18% (Gordis, 1969a), and 52% (Sievers, 1971), 
Our oldest patient with ARF was 63. The peak age (mode) 
was 9 years, agreeing with peaks of 10 years (McCue, 1970), 
II years (Tahernia, 1971), and 10-14 (Quinn, 1967). However, 
our mean age of 16,3 years is a bit higher than the well- 
known values of 10-12 years and can probably be explained by 
the fact that our curve was skewed by the number of patients 
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Figure 6 : Incidence of Rheumatic Fever Admissions by Month 
(composite of all admissions 1968-1972) 
JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC 
over 20 included in our survey who would not have been included 
in any studies of RF in children. Thus, if we calculate the 
mean for only our 5-25 year old admissions, we obtain 12,6, more 
in line with other reports, 
MONTH OF ADM 155 I ON - see figure 6 
The definite seasonal incidence of RF varies in different 
localities. On the west coast of the U.5., it peaks in January 
and February, on the east coast, in March and April, In general, 
the seasonal variation of RF follows that of streptococcal 
pharyngitis. (Markowitz, 1972) 
. 
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Figure 7: Length of Hospitalization for Rheumatic Fever in 
Connecticut, 1968-1972 
□ur admissions, combined for the 5-year period under con¬ 
sideration, showed the expected peak in March and April, with 
25% of the total admissions (113/446) occurring in those months, 
and following the characteristic pattern for the northeastern U,5, 
LENGTH DF HOSPITALIZATION - see figure 7 
The average length of hospitalization for ARF in Con¬ 
necticut, 1968-1972 was 14,6 days. The graph has peaks at 
both one and two weeks. The shortest admissions were 3 patients 
hospitalized for only 1 day; the longest was one patient hos¬ 
pitalized for 57 days. Thirty-seven patients (8%) were dis- 
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charged only after a month. 
The duration of hospitalization in the era prior to 
anti-inflammatory treatment revealed 20% remaining less than 
2 months, 30% remaining 2 to 4 months, and a full 50% remain¬ 
ing longer than 6 months (these hospitalization figures in¬ 
clude convalescence), (Baum, 1963) 
DISPOSITION 
The overwhelming majority of the admissions in our study 
terminated with discharge of the patient to his home, 91.5% 
(435/446), Four of our patients, 0,9% (4/446) were discharged 
to convalescent homes or to other hospitals for conval¬ 
escence; 1,4% (6/446) were discharged to other institutions 
(penal institutions, schools), and only 1 patient out of the 
446 died of ARF during the years of the study. The death 
rate from ARF has been continually declining, partially due 
to a decrease in incidence and partially due to a decrease in 
severity of the disease. 
In 1900, the estimated death rate per 100,000 population 
was 20 (Goldring, 1968), By 1920, the estimate had dropped in 
half to 10 per 100,000 (McCue, 1970). And in the early 
1960's, accounts ran as low as 0,4 per 100,000 (McCue, 1970 
and Goldring, 1968), The number of deaths in our study is 
too low to allow extrapolation for a mortality rate, but it 
seems to be in the expected range, 
J0IME5 CRITERIA - see figure 8 
"The renowned clinical , formulated in 1944 by 
v i iiev-a* 
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Figure 8: Jones Criteria Profile of All Admissions in Connecticut 
1968-1972 Diagnosed as Rheumatic Fever** 
MANIFESTATION 
MAJOR 
Carditis 
PERCENT WITH 
EVIDENCE OF 
MANIFESTATION 
25,1 (112/446) 
NUMBER WITH 
QUESTIONABLE 
EVIDENCE 
17 (3,8%) 
NUMBER OMITTED 
DUE TO LACK 
OF INFORMATION 
0 
Polyarthritis 87,2 (389/446) 1 (0.2%) 0 
Chorea 4.4 (18/405) 2 (0,5%) 41 (9,1%) 
E rythema 
Marginatum 8,9 (35/395) 4 (1,0%) 51 (11.4%) 
Subcutaneous 
Nodules 3.0 (12/395) 0 51 (11.4%) 
MINOR CLINICAL 
Fever (over 
100.4 F) 70,5 (313/444) 0 2 (0,5%) 
Arthralgia 93,1 (415/446) 0 0 
Previous Rheuma¬ 
tic Heart Dis¬ 
ease 6,3 (28/446) 5 (1,1%) 0 
Previous Rheuma¬ 
tic Fever 15,5 (69/446) 8 (1 .8%) 0 
MINOR LABORATORY 
Elevated Sedimen 
tation Rate 89,4 (397/444) 0 2 (0,5%) 
C-Reactive 
Protein 5 5,6 (180/324) 0 1 22 (27.4%) 
Leukocytosis 
(over 12,000) 35,1 (156/444) 0 2 (0,5%) 
Prolonged P-R 19,5 (85/436) 1 (0,2%) 1 0 (2,2%) 
**The denominator for the percent ; with evidence of manifestation 
and for the number with questionable evidence is the number of 
admissions for which sufficient evidence was found to allow 
categorization into yes, no, and questionable categories. It 
was derived by subtracting the number omitted due to lack of 
information from the total admissions in the study (446), 
. 
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T. Duckett Jones, and since then twice revised, have brought 
about a degree of diagnostic uniformity and provided a vitally 
needed standard for national and international cooperative 
RF studies." (Markowitz, 1972) 
The major Jones Criteria for the diagnosis of ARF are 
carditis, polyarthritis, chorea, erythema marginatum, and 
subcutaneous nodules. The minor criteria are comprised of 
(1) fever, (2) arthralgia, (3) previous RF or RHD, (4) acute 
phase reactants - either leukocytosis, elevated E5R, or pos¬ 
itive CRP, and (5) prolonged P-R interval on ECG. 
Carditis: The prevalence of carditis in our study was 
25% (112/446), This agrees well with the study performed in 
Malmo, Sweden which reports 26% (371/1434) admissions for ARF 
with evidence of carditis (Hall, 1961), Most other recent 
studies, however, give significantly higher values: 38% at 
Bellevue (Mayer, 1963), 43% in Manhattan (Brownell, 1973), 
42% at Irvington House (Feinstein, 1962b), 60% at the Medical 
College of Virginia Hospital (McCue, 1970), 63% in Czecho¬ 
slovakia (Sitaj, 1970), 83% in Southern Iran (Tahernia, 1971), 
80% in greater Miami (Saslaw, 1962), 85% in St, Louis (Gold¬ 
ring , 1968). 
Carditis is easily the most important manifestation 
of ARF from the point of view of diagnosis as well as serious 
consequences to the patient. (Bland, 1966) Its course may 
vary from a fulminating fatal case to a subclinical inflammation. 
’ 
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Figure 9 : Correlation of Race with Carditis in Connecticut 
Hospital Admissions for Rheumatic Fever 1960-1972 
WHITES 
80,0% (357/446) 
BLACKS 
20,0% (89/446) 
CARDITIS 
DIAGNOSED 80/446 32/446 
25,1% (112/446) 17.9% 7,2% 
CARDITIS NOT 
DIAGNOSED 262/446 55/446 
71.1% (317/446) 58.7% 1 2,3% 
CARDITIS 
QUESTIONABLE 15/446 2/446 
3.8% (17/446) 3,4% 0.5% 
Admissions omitted due to lack of information = 0 
Chi-Square = 7,266 Significant at ,027 with 2 degrees of freedom 
In our study, we found no correlation between carditis and 
sex or age; however, we found an increased incidence of cardi¬ 
tis in Blacks (see figure 9), Thirty-two of 112 cases of 
carditis (29%) were found in Blacks in spite of the fact that 
they made up only 20% of our total population of admissions. 
Polyarthritis: The prevalence of polyarthritis in our 
study was 87% (389/446), which agrees extremely well with 
recent studies of ARF: 92% (Sakssna, 1969), 84% (Hall, 1961), 
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Figure 10: Correlation of Race with Chorea in Connecticut 
Hospital Admissions for Rheumatic Fever 1968-1972 
WHITES 
78,8% (319/403) 
BLACKS 
21.2% (86/403) 
CHOREA 
DIAGNOSED 16/403 2/403 
4,4% (18/403) 4.0% 
0,5% 
CHOREA NOT 
DIAGNOSED 303/403 82/403 
95.1% (385/403) 75,1% 
20,4% 
Admissions omitted due to lack of information = 43 
Chi-Square = 8.522 Significant at ,015 with 2 degrees of freedom 
76% (Feinstein, 1962a), 80% (Sitaj, 1970), 88% (Saslaw, 1962), 
69% (Mayer, 1963), 85% (Goldring, 1968), 
We found no correlation between polyarthritis and sex, 
race, or age. 
Chorea: The prevalence of chorea in our study was 4,4% 
(18/405), In this, as in all subsequent situations in which 
the denominator is less than the 446 total admissions, the 
difference represents those cases for which insufficient in¬ 
formation was present to allow any categorization. Our figure 
agrees quite well with most recent studies of ARF: 4% (Tahernia, 
1971), 8% (McCue, 1970), 7% (Brownell, 1973), 5% (Saksena, 
1969), 7% (Hall, 1961), 4% (Feinstein, 1962a), 6% (Goldring, 
1 968) . 
. 
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No patients with chorea were found in our study over the 
age of 25, and 2/3 of the cases were found in patients 6-15 
years of age. This is in keeping with the known infrequency 
of the manifestation over the age of 16. (Massell, 1964) 
In spite of the well-documented propensity for females 
to develop' chorea, with the female to male ratio reported as 
1,7 - 2,4 to 1 (Hall, 1961), we were unable to demonstrate 
any correlation between chorea and sex. Eight of the 18 
cases (44%) of chorea occurred in males and 10 (56%) in fe¬ 
males, very close to the expected 9 for each sex, predicted 
by the 51/49 male:female ratio. However, we quite unexpect¬ 
edly found a correlation between chorea and race (see figure 
10) with a preponderance of Whites having the manifestation: 
90% of the cases of chorea, 16/18, were found in Whites, 
despite the fact that this group only made up 80% of the 
total admissions. 
Erythema Marginatum: The prevalence of erythema marginatum 
in our study was found to be 8,9% (35/395), which agrees 
reasonably well with recent studies: 1,1% (Sitaj, 1970), 3% 
(Tahernia, 1971), 15% (Goldring, 1968), 1.6% (Saksena, 1969), 
4% (Feinstein, 1962a), 
We found no correlation between erythema marginatum and 
sex, race, or age, 
Subcutaneous Nodules: The prevalence of subcutaneous 
nodules in our study was 3,0% (12/395) which agrees fairly 
' 
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well with recent studies on ARF: 1$ (Tahernia, 1971), 5$ 
(Goldring, 1968), 8,3$ (Saksena, 1969), and 1$ (Feinstein, 
1 962a) , 
We found no correlation between subcutaneous nodules 
and sex,or age. There were no Blacks in our study reported 
to have nodules, but the total number of admissions having 
evidence of the manifestation is so small as to preclude 
any conclusion of significance. In addition, the lack of 
Blacks with this manifestation may be explained simply by the 
difficulty in recognizing subcutaneous nodules on black skin, 
(Dimitriu, 1965) 
Fever: The prevalence of fever in our study was 70.5$ 
(313/444) which was a bit lower than most recent reports on 
ARF: 93$ (Sitaj, 1970), 97$ (Saslaw, 1962), 91$ (Feinstein, 
1962a), 92$ (Goldring, 1968), 73-80$ (Saksena, 1969). One 
of the possible explanations for this result was that our 
definition of fever was strict (equal to or greater than 
100,4°F, on at least one occasion), and may have been based 
on a higher temperature than were other studies. No other 
study clearly gave the definition of fever used. 
We found no correlation between fever and race or age, 
but, surprisingly, found a significant correlation between 
fever and sex, with males having a disproportionate number of 
the febrile admissions (see figure 11), 
Arthralgia: The prevalence of arthralgia in our study 
' 
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Figure 11: Correlation of Sex with Fever (over 100,4°F) in 
Connecticut Hospital Admissions for Rheumatic Fever 
1968-1972 
ADMISSIONS WITH 
FEVER 
70.5$ (313/444) 
ADMISSIONS 
WITHOUT FEVER 
29.5% (131/444) 
MALES 
50.9% (226/444) 
173/444 
39.0% 
53/444 
11.9% 
FEMALES 
49,1% (218/444) 
140/444 
31.5% 
78/444 
17,6% 
Admissions omitted due to lack of information = 2 
Chi-Square = 8,108 Significant at ,005 with 1 degree of freedom 
was 93% (313/444) which agrees reasonably well with the one 
other study in which it was measured in the same manner as 
in the present study. Our definition of arthralgia included 
all admissions in which arthralgia was a significant symptom, 
not excluding those in which polyarthritis would ultimately 
be used to satisfy the Jones Criteria, In the one study 
found in which arthralgia was similarly defined, 88% of the 
admissions gave evidence of the manifestation, (5aslaw, 1962) 
We found no correlation between arthralgia and race, sex, 
or age. 
2 
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Previous Rheumatic Heart Disease: The prevalence of 
previous RHD in our study was 6,3% (28/446), 
We found no significant correlation between previous 
RHD and race, sex, or age. 
Previous Rheumatic Fever: The prevalence of a previous 
attack of RF in our study was 15.5% (69/446), a significant¬ 
ly lower value than those recently reported for ARF : 31% 
(37/118) in a study of the British Army (Slater, 1959), 65% 
(Saksena, 1969), 33% (Saslaw, 1962), 48% (Sitaj, 1970). 
The variability among studies with regard to this parameter 
may be simply due to geographic and population differences in 
the prevalence of ARF and RHD as well as differences in 
diagnostic criteria. 
In Connecticut, of the 69 admissions mentioned as 
"having had" previous RF, only 49 (71%) had documented 
hospitalizations, while the remaining 20 (29%) merely replied 
in the affirmative to the question, "Did you ever have 
rheumatic fever?" 
No significant correlation was found between previous 
RF and race, sex, or age. 
Elevated Sedimentation Rate: The prevalence of an 
elevated ESR in our study was 89% (397/444) which agrees 
well with the 84% reported in the greater Miami area (Saslaw, 
1 962) . 
No significant correlation was found between elevated 
: lav:- o i - :.ju. ~ x ■/si S 
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ESR and race, sex, or age. 
Presence of C-Reactive Protein: The prevalence of a 
positive CRP in our study was 56% (180/324) which agrees 
moderately well with the 71% reported in the greater Miami 
area (Saslaw, 1962). 
No significant correlation was found between positive 
CRP and race, sex, or age. 
Leukocytosis: The prevalence of an elevated white 
blood cell count (WBC) in our study was 35% (156/444). It 
is difficult to compare our result with that of any other 
studies, since "leukocytosis” is ordinarily taken to mean 
simply any elevation of the WBC above the normal range for 
the hospital involved. In regard to this parameter, our 
definition was "a leukocytosis of equal to or greater than 
12,ODD per cubic millimeter on at least one occasion,” 
We found no correlation between leukocytosis and race, 
sex, or age, 
Prolonged P-R Interval on ECG: The prevalence of a 
prolonged P-R interval in our study was 19.5% (85/436), 
Due to the lack of a clearcut definition of a "prolonged 
P-R interval” in most studies, we are unable to make any 
cross-study comparisons. 
We found no correlation between prolonged P-R interval 
on ECG and race or age, but found a quite significant cor¬ 
relation with sex, a preponderance of males in our group 
■ 
v 
Figure 12: Correlation of Sex with Prolongation of the P-R 
Interval in Connecticut Hospital Admissions for 
Rheumatic Fever 1968-1972 
MALES FEMALES 
50,5% (220/435) 49,5% (216/435) 
PROLONGED P-R 
FOUND 57/435 
19,5% (85/435) 13,1% 
28/435 
6,4% 
PROLONGED P-R 
NOT FOUND 162/435 
80.3% (350/435) 37,3% 
188/435 
43,2% 
Admissions omitted due to lack of information = 11 
Chi-Square = 12,790 Significant at ,002 with 1 degree of freedom 
with prolonged P-R, 173/313 (55%), in spite of the fact that 
males made up only 51% of the total sample (see figure 12), 
A prolonged P-R interval is found so frequently in other 
childhood illnesses that it has little 'weight as a diagnostic 
test for ARF» It is not a sign of acute carditis and has no 
real prognostic import, (McCue, 1970) 
SUPPORTING EVIDENCE OF PRECEDING STREPTOCOCCAL INFECTION - see 
figure 15 
The modified Jones Criteria emphasize the supporting 
evidence of a preceding group A beta-hemolytic streptococcal 
infection. Verification of a recent streptococcal infection 
is a necessary ingredient for diagnosis. Acceptable supporting 
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evidence is comprised of either (1) recent recognized scarlet 
fever, (2) a positive throat culture for group A streptococci, 
or (3) an elevated anti-streptolysin 0 titer. (Ad Hoc Committee 
of the Council on Rheumatic Fever, 1965) 
Recent Scarlet Fever: The prevalence of recent scarlet 
fever in our study was 1 »65^ (7/444), I\lo significant correla¬ 
tion was found between recent scarlet fever and race, sex, 
or age, 
Positive Throat Culture: The prevalence of positive 
throat culture in our study was 23% (75/321) which agrees 
well with studies in the recent literature: 39% (Saslaw, 1962), 
29% (Gordis, 1969a), 23% (McCue, 1970), No correlation was 
found between positive throat culture and race, sex, or age. 
Of the 440 admissions on which we have information, we 
find that throat cultures were taken on 90% (397/440) and 
were omitted in 10% (43/440) of the cases (see figure 13), 
Of the 397 cultures taken, 61% (322/397) were negative for 
group A beta-hemolytic streptococci and only 19% (75/397) 
were positive. And of those 322 cultures found to be neg¬ 
ative, 24% (76/322) were obtained after the patient had begun 
antibiotic therapy, either as an outpatient or in the hospi¬ 
tal. 
These results point up the need for taking cultures from 
each patient in whom the diagnosis of ARF is considered, and 
in taking these cultures before antibiotics are begun. 
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Figure 13 : Analysis o£ Inpatient Throat Cultures Among 446 
Hospitalizations in Connecticut for Rheumatic 
Fever 1968-1972 
THROAT CULTURE 
6 admissions omitted due to 
insufficient information 
OBTAINED NOT OBTAINED 
90.21 (397/440) 9.8% (43/440) 
POSITIVE FOR GROUP A 
STREPTOCOCCI 
17.1% (75/440) 
NEGATIVE FOR GROUP A 
STREPTOCOCCI 
73.2% (322/440) 
CULTURED AFTER 
START OF 
ANTIBIOTICS 
17.3% (76/440) 
CULTURED BEFORE 
START OF 
ANTIBIOTICS 
55.9% (246/440) 
1 
l 
i 
4 
* 
4 
I 
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Elevated Antistreptolysin 0: Antibody to streptolysin 
0 begins generally to rise 7—10 days after a streptococcal 
infection and reaches a peak at 3-5 weeks. The antibody re¬ 
sponse is quantitatively greater in patients who develop RF 
but there is so much variation in the titer that the magni¬ 
tude of the rise is not itself of diagnostic value. The titers 
return to normal in 2-4 months and therefore are usually 
normal in the chronic stages of rheumatic disease, (Feinstein, 
1962b) 
A50 can be demonstrated in 70-60/3 of patients following 
an untreated pharyngeal infection with group A streptococci * 
But prompt antibiotic treatment may suppress the A50 response. 
(McCue, 1970) 
The prevalence of elevated AS0 titers in our study was 
78% (337/432) a value in very good accordance with other re¬ 
ported values: 89% (Hall, 1961), 71% (Saslaw, 1962), 78% 
(G ordis, 1 9 69 ), 
However, a single value of antibody titer, no matter how 
high or low, does not demonstrate or exclude a recent strep¬ 
tococcal infection. The important aspect of antibody titer 
is a change in values, rather than any single reading, A 
single titer can be as high as the residuum of an even higher 
value from an old infection, whose titer has slowly decayed, 
and a low or normal value might represent a rise from an even 
lower previous titer in that patient, (Feinstein, 1966) 
. 
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Figure 14: Percent of Admissions with Elevated A50 (above 166) 
By Age Group 
AGE IN YEARS 
No significant correlation was found between elevated 
A50 titer and race or sex, but an interesting variation with 
age was demonstrated (see figure 14), The A50 response follow¬ 
ing a streptococcal infection has been said to increase from 
infancy through childhood, with almost all patients over the 
age of 5 responding with an increased titer, (Ferencz, 1969) 
In our study, we found that only 52% (13/25) of the admissions 
of children under the age of 6 had an elevated A5G, whereas 
86% (223/258) of those ages 6-15 had elevated titers. After 
the age of 15, the percent of positives began to drop, to 
68% (28/41) ages 16-20, and 56% (22/39) ages 21-25, We can 
see from figure 14 that only during the years 6-15 do we find 
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a greater per cent of positives than the overall 78$ average, 
DIAGNOSTIC VALIDITY - see figure 16 
The widespread application of the Jones Criteria has 
brought major progress to the study of ARC, because the 
population of patients under surveillance can now be defined 
more precisely than ever before. They are not perfect, no 
arbitrary decisions about disease ever can be, but at least 
they enable physicians to circumscribe a zone of the differ¬ 
ent types of human illness to be considered as candidates for 
the diagnosis of ARF, The manifestations cited by the Jones 
Criteria, however, can be produced by many major diseases 
other than ARF, These masqueraders can oft be identified 
by specific diagnostic tests for gout, sickle cell disease, 
rheumatoid arthritis, or systemic lupus erythematosis. 
(F einstein, 1 9 66) 
"The presence of two major criteria, or of one major 
and two minor criteria, indicates a high probability of 
the presence of rheumatic fever. Evidence of a preceding 
streptococcal infection greatly strengthens the possibility 
of ARF. Its absence should make the diagnosis doubtful." 
(Ad Hoc Committee of the Council on Rheumatic Fever, 1965) 
The Jones Criteria are indeed a useful tool in helping 
to diagnose ARF; however, there are loudly voiced objections 
to overly strict adherence from some quarters (Okuni, 1971). 
Hence, while a discussion of the validity of diagnoses with 
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Figure 15: Supporting Evidence of Preceding Streptococcal Infection 
in All Admissions in Connecticut 1968-1972 Diagnosed as 
Rheumatic Fever 
MANIFESTATION PERCENT WITH 
EVIDENCE OF 
MANIFESTATION 
NUMBER WITH 
QUESTIONABLE 
EVIDENCE 
NUMBER OMITTED 
DUE TO LACK 
OF INFORMATION 
Elevated A50 
(over 166) 78*0 (337/432) 0 1 4 (3,1%) 
Positive Throat 
Culture for 
Group A 
Streptococcus 23*4 (75/321) 0 49 (11.0%) 
Recent Scarlet 
F ever 1,6 (7/444) 0 2 (0.5%) 
Figure 16: Analysis of Case Validity in Connecticut Admissions 
1968-1972 Diagnosed as Rheumatic Fever 
PERCENT OF ADMISSIONS 
SATISFYING CRITERIA 
PERCENT OF ADMISSIONS 
NOT SATISFYING CRITERIA 
Jones Criteria 94.2 (420/446) 5,8 (26/446) 
Supporting Evid¬ 
ence of Strep 
Infection 
(ASO, Scarlet 
Fever, Culture) 81,6 (364/446) CD • (82/446) 
Jones Criteria 
and Supporting 
Evidence 78,0 (348/446) 22,0 (98/446) 
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respect to the Jones Criteria must certainly be included in 
any complete study of ARF, we have not rejected those admis¬ 
sions from our study which did not fulfill them. 
The prevalence of admissions which satisfied the Jones 
Criteria was 94% (420/446) which agrees well with previously 
reported figures: 95% (Spector, 1968), 80% (Gordis, 1969a), 
93% (Saslaw, 1962), 90% (Hall, 1961), 
Of the 420 cases satisfying the criteria, 120 (29%) had 
evidence of two major criteria, 291 (69%) had evidence of one 
major and two minor criteria, and 9 (2%) had evidence of 
chorea associated with less than two minor criteria. 
We found no significant correlation between satisfying 
of the Jones Criteria and race, sex, or age. 
One or more pieces of supporting evidence of a strepto¬ 
coccal infection was found in 82% (364/446) of the admissions 
under study. Of the 364 with supporting evidence, 280 (77%) 
had only an elevated A50 titer, 22 (6,5%) had only a positive 
throat culture, 5 (1.4%) had only scarlet fever, 55 (15%) 
had both a positive throat culture and an elevated A50 titer, 
and 2 (0,1%) had both scarlet fever and an elevated A50 titer. 
The percentage of admissions qualifying as ARF by the 
strictest criteria (satisfaction of the Jones Criteria to¬ 
gether with evidence of preceding streptococcal infection) 
was 78% (348/446), This means that only 22% (98/446) did 
not fulfill the most rigorous requirements to meet the 
. 
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diagnosis of ARF, and seems quits good in a statewide study 
of a disease as difficult to diagnose as is ARF, 
PRIMARY PREVENTION OF RHEUMATIC FEVER 
Rheumatic fever occurs in 0.3 to 3,0^ of untreated strep¬ 
tococcal pharyngitis. (Rammelkamp, 1952), (Siegel, 1961) Both 
initial attack and recurrence of ARF follow a characteristic 
pattern. A streptococcal pharyngitis, severe, mild, or sub- 
clinical occurs. When symptoms are present, they subside 
in 3-4 days unless there are suppurative complications. The 
patient appearswell for a period of time. And this is fol¬ 
lowed by the appearance of ARF, (Feinstein, 1964) 
Characteristically, the clinical manifestations of ARF 
appear 1-6 weeks after the pharyngitis. The mean duration of 
the latent period between the onset of the infection and the 
appearance of rheumatic symptoms has been reported to be 18.6 
days, (Baum, 1 963 ) It is reported that 24/£ of patients ex¬ 
perience a latent period greater than 35 days; however, many 
of these may be reinfections. It is said that 7% have latent 
periods of less than 5 days and a few patients have been men¬ 
tioned in whom the symptoms of ARF coincided with the onset 
of the respiratory illness. The length of the latent period 
does not appear to be related to the specific type of group 
A streptococcus, the height of the A50 titer, or to the clin¬ 
ical pattern of the rheumatic episode. (Rammelkamp, 1962) 
"Primary prevention or prophylaxis of ARF refers to the 
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adequate treatment of a streptococcal infection in a patient 
who has not had RF and who will, by prompt and complete erad¬ 
ication of the organism, be protected from any late, non-sup- 
purative complications," (Ferencz, 1969) 
It is no secret that the battle against the strepto¬ 
coccus is, by and large, mounted against tremendous odds. 
The organism is ubiquitous; it is difficult and sometimes 
impossible to distinguish carrier states from true infections; 
(Dunlap, 1973) many infections occur in asymptomatic or mildly 
symptomatic children who never reach medical attention (Noble, 
1972); throat cultures are not infallible; and effective 
treatment is difficult to achieve, (Brett, 1972), (Markowitz, 
1 968 ) 
As a result of the findings during an epidemic of strep¬ 
tococcal pharyngitis in a military training center in 1950, 
it is now established that the administration of adequate 
doses of penicillin for ten days to patients with scarlet 
fever or streptococcal pharyngitis may prevent the appearance 
of RF (Denny, 1950), Treatment for a full 10-day period is 
essential to eliminate streptococci from the nasopharynx. 
If antibiotics are only given for a few days, the organism 
may persist in the throat and RF may develop. 
One of the major factors limiting the prevention of 
initial attacks of ARF by using antibiotics is that about 
two thirds of the patients who develop ARF do so following 
3 L q inca iv t j st u q 
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either asymptomatic or mild streptococcal infections. Fur¬ 
thermore the lower socioeconomic groups, in which the risk 
of RF is the greatest, are the least likely to receive ade¬ 
quate care for an acute respiratory infection, (Markowitz, 
1 969 ) 
In our study, we found that 66% (254/386) of the ad¬ 
missions were preceded by acknowledged respiratory tract 
infections (see figure 17), Of our total 446 admissions, 
60 were omitted due to lack of information. Our 66% figure 
is in exact agreement with the data from a similar study done 
in Baltimore in which it was found that 66% (of 261 patients) 
acknowledged a prior respiratory infection (Markowitz, 1970), 
and agrees well with other reported figures: 68% (Slater, 
1959), 51% (Gordis, 1969a), 64% (Sitaj, 1970), In both the 
Baltimore study and our own in Connecticut, the estimate for 
asymptomatic or mildly symptomatic infections would thus be 
34%. 
Of the 235 respiratory infections in which we have infor¬ 
mation (19 of the 254 were omitted due to lack of information), 
we found that 44% (104/235) were seen by a physician and 56% 
(131/235) were not seen. Presented in a different way, we 
see that 27% (104/386) of the total were seen by a physician. 
This figure is similar to results of 34% (of 261 patients) in 
Baltimore (Markowitz, 1970) and 33% (35/105) in Boston (McCue, 
1 970) , 
Of the 104 seen by a physician, we have no information 
' 
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Figure 17: Respiratory Tract Infections Preceding Connecticut 
Hospitalizations for Rheumatic Fever 
PRIOR RESPIRATORY INFECTION 
omitted 
insufficient 
due to 
information 
£L.-- 
ACKNOWLEDGED 
65.0% (254/386) 
DENIED 
34.2% (132/386) 
1111 
SEEN BY. M , D , 
44.3% (104/235) 
(43) 
NOT SEEN BY M.D 
55.7% (131/235) 
(16) 
TREATED 
89.7% (79/88) 
NOT TREATED 
10.3% (9/88) 
THROAT 
CULTURED 
63.9% (39/61) 
NOT 
CULTURED 
36.1% (22/61) 
■(22) 
POSITIVE FOR 
GROUP A 
STREPTOCOCCUS 
71.8% (28/39) 
NEGATIVE FOR 
GROUP A 
STREPTOCOCCUS 
29.2% (11/39) 
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regarding therapy in 16, Of the remaining 88, 90% ( 79/88 ) 
were ’’treated" and 10% (9/86) were not treated. The break¬ 
down of the "treatment" was as follows: 12 of 88 were treated 
with penicillin intramuscularly (14%), 12 (14%) were "treated" 
with no further information, 10 (11%) claimed to have continued 
oral therapy for 10 full days, 32 (36%) admitted to either 
not taking their antibiotic at all or taking it for less than 
10 days, and 22 (25%) had oral antibiotics prescribed for 10 
days, but did not mention whether or not they we re taken. 
To evaluate patient cooperation in carrying out the re¬ 
commended 1 0-day treatment course of penicillin prescribed 
for streptococcal pharyngitis or otitis media, a study was per¬ 
formed utilizing both a urine test for the presence of peni¬ 
cillin and home visits with pill counts. We find that in 
spite of the special attention resulting from the study itself, 
only about 50% of private patients and 20% of clinic patients 
completed the full course of treatment, although over 80% 
of the clinic mothers reported that the recommendations had 
been carried out, (Ferencz, 1969) 
Of the 88 patients in our study seen by a physician for 
a respiratory infection, 67 (77%) were seen by private phy¬ 
sicians and 21 (23%) were seen in hospitals, either outpatient 
clinics or emergency services. 
We have information on 61 of the 104 patients seen by 
a physician with regard to throat culture (43 were excluded 
because of insufficient information). Sixty-four per cent 
■ 
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(39/61) had their throats cultured while 36% (22/61) did 
not. Of those who did have throats cultured, we have in¬ 
formation on the results in 39 cases (22 were omitted be¬ 
cause of lack of information). Of these 39, 28 or 71% were 
positive for group A streptococcus and 11 or 29% were nega¬ 
tive. 
Thus, 79 of our 446 admissions have at least had a 
history of having antibiotics prescribed for them (19%), and 
12 received intramuscular therapy; yet they still developed 
RF. This is certainly one area in which improvements can 
be made both through further education of physicians and 
through programs to improve compliance of patients, 
RHEUMATIC HEART DISEASE AT TIME OF DISCHARGE - see figure 18 
It has been taught for many years that 60-80% of patients 
with clinically detectable carditis during an attack of ARF 
are left with residual RHD, although in many the clinical 
findings of RHD may not appear until months or years after 
discharge, (Spagnuolo, 1971), (Baum, 1963), (Wenger, 1967) 
The declining severity of RF can be judged by the de¬ 
crease in cardiac involvement seen in patients hospitalized 
with ARF, Generally speaking, the prognosis for any child 
with the disease is directly related to the severity of the 
carditis, Mayer (1963) reported that among children discharged 
from Bellevue Hospital the percentage of total cases with 
organic heart disease had decreased to 21% between 1951- 
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Figure 18: Rheumatic Heart Disease at Time of Discharge in 446 
Connecticut Admissions for Rheumatic Fever 1968-1972 
PERCENT HAVING 
RHEUMATIC HEART 
DISEASE 13,8 (61/443) 
PERCENT NOT HAVING 
RHEUMATIC HEART 
DISEASE 83,5 (370/443) 
PERCENT WITH 
QUESTIONABLE 
EVIDENCE 2,7 (12/443) 
NUMBER OMITTED 
DUE TO LACK OF 
INFORMATION 3/446 (0.7%) 
1958 from 37% between 1935-1950, Massell (1964) found that 
at the House of the Good Samaritan (a regional hospital for 
the acute and convalescent care of RF) the population of 
patients with RHD decreased from 73% 1921-1930 to 51% in the 
period 1951-1960, 
In our study, the prevalence of RHD at the time of dis¬ 
charge was found to be 14% (61/443) or 54% (61/112) of those 
manifesting carditis during hospitalization, 
We found no significant correlation between RHD at 
discharge and sex or age, but did find an increased preval¬ 
ence of RHD among Blacks (see figure 19), Thirty-three per 
cent (20/61) of the RHD at discharge was found in Blacks 
even though they made up only 20% of the total admissions. 
' 
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Figure 1 g: Correlation of Race with Rheumatic Heart Disease 
at Discharge Among Connecticut Hospital Admissions 
for Rheumatic Fever 1968-1972 
WHITES 
80,1$ (355/443) 
BLACKS 
19,9$ (88/443) 
RHD FOUND AT 
DISCHARGE 
13.8$ (61/443) 
41/443 
9.3$ 
20/443 
4,5 $ 
RHD NOT FOUND 
AT DISCHARGE 306/443 
83.5$ (370/443) 69,1$ 
64/443 
1 4,5$ 
QUESTIONABLE 
EVIDENCE OF RHD 8/443 4/443 
AT DISCHARGE 1 ,8$ 0.8$ 
2.7$ (12/443) 
Admissions omitted due to lack of information = 3 
Chi-Square = 9.298 Significant at ,010 with 2 degrees of freedom 
SECONDARY PROPHYLAXIS OF RHEUMATIC FEVER 
The prevention of streptococcal infection among patients 
who have had an attack of RF is of extreme importance because 
these patients are particularly susceptible to a rheumatic 
recurrence. (Gordis, 1971) It has been determined that 20- 
50$ of susceptible patients not receiving antimicrobials 
might be expected to have such recurrences, (Baum, 1963), 
(Johnson, 1964) 
Thomas Sydenham was the first to realize that rheumatic 
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patients were "very subject to a relapse, , ,It is proper 
to bleed and purge the patients for some days about the 
same season the next year, or a little earlier," 
Recurrent RF can be defined as "the reappearance of such 
RF manifestations as would be sufficient to make a diagnosis 
of a first attack, after a period of quiescence not result¬ 
ing from treatment," Manifestations of RF may fluctuate 
and reappear after total suppression by treatment, in which 
case the term rebound or relapse can be used. But experi¬ 
ence shows that such relapses fall within two months of the 
end of treatment and usually within two weeks. New or re¬ 
newed manifestations two months or more after treatment is 
stopped have been shown to follow a new streptococcal infectin. 
(T aranta, 1 967) 
Secondary prevention or prophylaxis of RF refers to the 
protection of those with a histoi-y of RF from streptococcal 
infections, which might reactivate the disease. In other 
words, it means the maintenance of the patient in the strep¬ 
tococcus-free state achieved by the original treatment course. 
Either penicillin or sulfonamide is effective in a small daily 
dose as long as it is conscientiously taken. Failures occur 
in spite of faithful compliance, but are mostly due to pati¬ 
ents' failure to take the medication, (Ferencz, 1969) 
Antibiotic agents which can prevent beta-hemolytic strep¬ 
tococcal infections became available in 1936, Because of the 
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high recurrence rate of RF, daily doses of sulfonamides were 
tried as a prophylactic measure to prevent streptococcal in¬ 
fections in rheumatic subjects in convalescent homes and pedi¬ 
atric cardiology clinics. Well-controlled studies showed 
that by this procedure, streptococcal pharyngitis could be 
prevented and that the recurrence rate of RF was grossly 
reduced. Subsequently, similar results were obtained with a 
daily oral dose of penicillin, (Markowitz, 1972) 
The general consensus is that a monthly injection of 
benzathine penicillin is by far the most effective regimen. 
Using this program, the recurrence rate was 0,4 per 100 pa¬ 
tient years, as compared with a rate of 5,5 for similar pa¬ 
tients on daily oral penicillin, and 10,7 on oral penicillin 
for only 10 days per month, (Spagnuolo, 1973) 
Although the number of recurrent attacks has been re¬ 
duced, approximately 10/6 of rheumatic patients still develop 
recurrences either because they are not on prophylaxis at all 
or they take their medication irregularly, (Markowitz, 1972) 
In one study, we find that, after one year, only 20-60% 
of the patients had continued prophylaxis (by urine test), 
(Ferencz, 1969) In another study done in Baltimore, only 
32% of the patients were found to take their medication more 
than 75% of the time (by urine test), and over 36% took their 
medication less than 25% of the time, (Markowitz, 1970) In 
a study done at Yale-New Haven Hospital, it was found that 
less than 1% of teenagers maintained regular prophylaxis 
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Figure 20: Rheumatic Fever Recurrences Among Hospitalizations in 
Connecticut for Rheumatic Fever 1968-1972 
First Attacks 
Recurrences 
Second Attacks 
Third or More 
Undifferentiated 
Recurrences 
Omitted Due to Lack 
of Information 
84*6$ (373/441) 
15,4$ (68/441) 
10,4$ (46/441) 
2.5$ (11/441) 
2,5$ (11/441) 
5/446 (1,1$) 
Figure 21: Prophylaxis Among 68 Recurrent Attacks of Rheumatic 
Fever in Connecticut 1968-1972 
On Rheumatic Fever 
Prophylaxis 53,7$ (36/67) 
Not on Rheumatic Fever 
Prophylaxis 46,3$ (31/67) 
Omitted Due to Lack of 
Information 1/68 (1,5$) 
(Whittemore, 1966). 
In our study, we found that 85$ (373/441) of our ad¬ 
missions were for first attacks of ARF and 15$ (68/441) were 
recurrences. This figure is in accordance with the findings 
of other authors: 15$ (Gordis, 1969a), 20$ (Brownell, 1973), 
13$ (Saslaw, 1962), The recurrences (figure 20) can be fur¬ 
ther broken down: 46 (10$) were documented second attacks, 
11 (2,5$) were third or greater attacks, and 11 (2.5$) were 
not differentiated. 
We must remember that recurrence rates judged by history 
i 
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miss all those first attacks manifest by silent carditis and 
count those erroneously diagnosed. In a patient group ages 
11-22 with a prior history of ARF and not on prophylaxis, 
the streptococcal infection rate was 24,3 per 1□□ patient 
years as measured by bimonthly serum antibody levels. Of these, 
83/o were asymptomatic and were not treated, (Findlan, 1970) 
If we compute the recurrence incidence for Connecticut, 
1968-1972, we arrive at the figure 0,5 per 100,000 total 
population. Considering only recurrences occurring in pa¬ 
tients ages 5-20 we find 33 recurrences in a population of 
about 900,000 (Connecticut population ages 5-20, 1972 esti¬ 
mate), or an incidence of 3.7 per 100,000 ages 5-20, The 
study in Baltimore (Gordis, 1969a) reported a recurrence 
incidence of 2.3 per 100,000 ages 5-19, 
We find that of the 68 recurrent attacks in our study, 
36 (54%) occurred while "on prophylaxis” (figure 21), Thus, 
36 of our total 446 admissions (8%) had at least had some type 
of prophylactic medication prescribed for them. This agrees 
extremely well with other reports: 7% (Ferencz, 1969), 10% 
(Brownell, 1973), 9% (Taranta, 1967), 
In an effort to further differentiate our patients "on 
prophylaxis" we found that of the 36 claiming to be on a reg¬ 
imen, 17 (47%) admitted to not taking their medication reg¬ 
ularly, only 5 (14%) claimed that they did take the medication 
regularly, and in 17 cases we have no information regarding 
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regularity, 
CONNECTICUT RHEUMATIC FEVER REGISTRY - see figure 22 
It is important to note that the Connecticut Heart 
Association Rheumatic Fever Registry provides only oral 
penicillin; therefore, it may well be that some patients 
have been put on other treatment regimens, and remain un¬ 
registered, (Teagle, 1963) 
With regard to utilization of the registry, we found 
that 195 (44%) of our 446 admissions were reported to the 
registry, as compared to 61% reported to the Maryland reg¬ 
istry (Gordis, 1969c), Of those reported in order to ob¬ 
tain low-cost penicillin prophylaxis, the majority, 59% (115/195) 
were reported less than a month after their admission for 
ARF; 24% (47/195) were reported between 1 and 6 months, 4,6% 
(9/195) were reported between 6 months and one year, and 
12,3% (24/195) were reported a year or more after admission. 
One hundred forty of the 195 originally reported to the 
registry (72%) were on active registry as of December, 1973, 
While the rate of those still registered is being measured 
over little mors than a year for those patients admitted in 
1972, it agrees well with the 68% reported in Maryland (Gordis, 
1 969c) , 
We were unable to find any significant correlation be¬ 
tween a patient's being registered and race, sex, or age, and 
found that having had carditis, RHD, chorea, or a recurrence 
had no effect on his being registered or not. 
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Figure 22: Utilization of the Rheumatic Fever Registry of the 
Connecticut Heart Association 
REPORTED TO REGISTRY? 
DIED REPORTED NOT REPORTED 
0,2% (1/446) 43,7% (195/446) 56,1% (250/446) 
59.0% 24,1% 4,6% 12,3% 
(115/195) (47/195) (9/195) (24/195) 
' 
T* t 
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DISCUSSION AND RECOMMENDATIONS 
In 1930, Glover wrote that "the incidence of acute 
rheumatism seems to show that it, like tuberculosis, is 
slowly but surely being conquered, , .We seem to be seeing 
the same process of epidemiological obsolescence in acute 
rheumatism that Creighton saw in smallpox," (Markowitz, 1972) 
Glover’s prediction of obsolescence has not yet been fulfilled 
and the data presented from our study indicate that it is 
still a problem of considerable magnitude. 
The overall incidence of ARF seems to have declined, as 
has its mortality rate, and severity. A much lower per¬ 
centage of patients with RF seem to be presenting with car¬ 
ditis or ultimately developing RHD, However, we might take 
a note of warning from our comrades in Missouri: With no 
deaths from ARF in the years 1955-1966, "it was not surpris¬ 
ing that admitting officers and staff at 5t, Louis Children's 
Hospital had been lulled into a sense of unawareness about 
RF, This was so until 1967 when they were jolted into the 
realization that the disease was very much with us when two 
patients admitted with fulminating ARF died," (Goldring, 1968) 
(1) Viith RF a reportable disease in Connecticut and only 
5-10% of hospitalized cases of ARF being reported to the state 
and certainly an even lower proportion of total cases, the 
decision must be made as to whether RF should continue to be 
reportable. If so, measures must be taken to encourage report 
ing , 
* 
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(2) Efforts at primary prevention should be increased. 
There is no current method of primary prevention for those 
who have had no antecedent history of respiratory infection; 
of those who did have an infection, but did not see a phy¬ 
sician, there is an apparent need for increased community 
health education and probably increased availability of 
medical care. For the remaining who were seen by a physician 
there is no doubt that an educational program aimed at the 
doctors is indicated with particular reference to the appro¬ 
priate use of throat cultures and a review of general medical 
principles for the treatment of upper respiratory infections. 
The cost of RF was estimated in 1965 to be $22,324. per 
patient (onset of the disease to death), or $465 per year per 
patient (Saslaw, 1965). With these figures in mind, and the 
knowledge that the cost must be far higher in this decade, 
it certainly seems financially sound to continue and expand 
programs for primary prophylaxis of RF, those aimed at prevent¬ 
ing initial attacks., 
(3) In view of the extent and distribution of the RF 
problem in Connecticut, it seems well-advised to continue 
secondary prophylaxis programs, including the Heart Associ¬ 
ation's Registry (’which, with nearly 50% of the hospitalized 
cases reported to it, seems to be the only fairly reliable 
source at present for gauging the extent of the disease). 
Improvements in the system might include offering intramus- 
fit tdubb on g£ g-xsrlt 
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cular penicillin and oral sulfonamides as alternatives for 
prophylactic regimen, and stressing compliance with the help 
of visiting nurses or telephone calls. 
(4) Equally as imprtant as any of these prophylaxis 
measures is the continued education of physicians with regard 
to diagnosis and treatment of ARF. Although the Jones diag¬ 
nostic criteria have been purified, amended, and classified, 
we still have no pathognomonic test for RF. It is still 
essential that in any patient in whom the disease is considered, 
a good history be obtained and a thorough work-up performed, 
including throat culture, A50, E5R, CRP, and ECG, before be¬ 
ginning antibiotics. Only by continued awareness of the dis¬ 
ease and preparedness to make the diagnosis, can we hope to 
continue effective and prompt treatment in this potentially 
acutely fatal process, 
(5) It might be worthwhile to repeat this study in several 
years, with the view of defining any changes over the time 
period and reassessing the need for and the effect of the 
various prophylaxis programs in the state. 
. 
■ 
■ 
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SUMMARY 
A retrospective chart review of all hospital admissions 
for acute rheumatic fever (by discharge diagnosis) in the 
state of Connecticut was performed for the years 1968 to 1972. 
A total of 446 admissions, representing 431 patients were 
found, an average of 89 admissions per year or 3.0 admissions 
for ARF per 100,000 total population per year. 
The number of recurrences in this group was 68 (14%), 
giving us an incidence for recurrent RF of 0,5 per 100,000 
total population, or 3,7 per 100,000 ages 5-19, Of the 68 
recurrences, 31 (46%) admitted to being on some type of sec¬ 
ondary prophylaxis regimen, but only 5 claimed to take the 
medication regularly. 
Our sample was composed of equal numbers of males and 
females (51% males, 49% females), and the ratio of Whites to 
Blacks was found to be 4:1, 
Although the peak age of admission was 9, our "average 
admission" was 13 years of age, and remained in the hospital 
for 12 days, after which he was discharged home. The most 
common constellation of manifestations was polyarthritis 
associated with fever and an elevated sedimentation rate. 
Only 25% (112/446) of our admissions showed evidence of card¬ 
itis, and, of those, 54% (61/112) had rheumatic heart disease 
at the time of discharge. 
Ninety-four percent of our sample (420/446) satisfied the 
Jones diagnostic criteria, 82% (364/446) had supporting evi¬ 
dence of a preceding streptococcal infection, and 78% (348/446) 
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fulfilled both requirements of validity. 
At least 254 admissions were preceded by acknowledged 
respiratory tract infections; however, we know of only 104 
cases in which a physician was seen, only 79 who received 
antibiotic treatment, and only 39 in whom a throat culture was 
obtained, 
In our investigation of the Connecticut Heart Association 
Rheumatic Fever Registry, we found that 44% (195/446) of our 
admissions were reported to the registry for the purpose of 
obtaining penicillin at low cost for prophylaxis, most within 
one month of their hospitalization for ARF, In addition, 72% 
(140/195) of those reported are still on the active registry. 
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APPENDIX 
1, Letter introducing our study to the Chief Administrator 
and the Chief Medical Librarian at each hospital 
2, Coding form used to record all data on patients 

CONNECTICUT HEART ASSOCIATION 
-74- 
Dear 
For many years, the Connecticut Heart Association has been active 
in programs aimed at the prevention and control of rheumatic fever. 
In order to plan effectively for the future and to determine the needs of 
the State in this area, we are conducting a study of the number of cases 
of the disease in Connecticut. Since the clinical pattern and the severity 
or rheumatic fever has been changing through the years, we are surveying 
the hospital records to form a clinical profile of rheumatic fever. 
We are writing you, therefore, to request permission and to acquaint 
you with this project. We should like to review the records of all patients 
at your hospital from 1967-1972 inclusive with a diagnosis of acute rheumatic 
fever. This information will, of course, be kept completely confidential 
and will be used only to help plan the Heart Association program. No 
attempt will be made to contact these patients. 
We are requesting that a medical student, Mr. Harry Magnes, YMS '74, 
review these records according to our protocol. He will be under the 
direction of Dr. Ruth Whittemore, Clinical Professor of Pediatrics at the 
Yale University School of Medicine and Dr. Milton Markowitz, Professor 
and Director of Pediatrics at the University of Connecticut School of Medicine. 
Mr. Magnes will be in contact with your medical librarian in the relatively 
near future to arrange how he may best review records in your hospital 
with the diagnosis of acute rheumatic fever between 1967-1972. 
The information we obtain will be invaluable in helping us plan services 
for prevention and control of rheumatic fever in Connecticut, and we would 
greatly appreciate any assistance you feel would contribute to the success 
of this study. If you have any questions, please do not hesitate to contact 
any of us listed below. Thank you for your interest and cooperation. 
Sincerely yours, 
Victor Hurst, M. D. 
Chairman, Rheumatic Fever Committee 
P. S. The address of Mr. Harry Magnes is 1 South St. , New Haven 06510 
Telephone numbers of 
Dr. Hurst-Waterbury- 573-6000 
Dr. Whittemore-New Haven-436-8310 
Dr. Markowitz-Hartford- 243-2531, ext. 351 
Ruth Whittemore, M. D. 
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